ChemicalBook >제품 카탈로그 >생화학 공학>억제제>단백질 티로신 키나아제>WZ4002

WZ4002

WZ4002 구조식 이미지

카스 번호:: 1213269-23-8

상품명:: WZ4002

동의어(영문):: WZ4002;CS-166;WZ4002(HBr);WZ4002, >=98%;WZ4002 USP/EP/BP;WZ4002;WZ 4002; WZ-4002;WZ 4002 N-[3-[[5-Chloro-2-[[2-methoxy-4-(4-;N-{3-[(5-Chloro-2-{[2-methoxy-4-(4-methyl-1-piperazinyl)phen...;N-(3-(5-Chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acr;N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide

CBNumber:: CB52501012

분자식:: C25H27ClN6O3

포뮬러 무게:: 494.97

MOL 파일:: 1213269-23-8.mol

MSDS 파일:: SDS

속성

안전

용도

공급 업체 197

WZ4002 속성

밀도: 1.314

저장 조건: Store at -20°C

용해도: ≥24.7 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH

물리적 상태: 고체

물리적 상태: 단단한 모양

산도 계수 (pKa): 12.78±0.70(Predicted)

안전

WZ4002 C화학적 특성, 용도, 생산

용도

A novel mutant-selective EGFR kinase inhibitor of EGFRL858R and EGFRL858R/T790M with IC50s of 2 nM and 8 nM, respectively.

WZ4002 준비 용품 및 원자재

원자재

준비 용품

WZ4002 공급 업체

글로벌( 197)공급 업체

공급자	전화	이메일	국가	제품 수	이점
Nanjing Gold Pharmaceutical Technology Co. Ltd.	025-84209270 15906146951		CHINA	115	55
Beijing Cooperate Pharmaceutical Co.,Ltd	010-60279497	sales01@cooperate-pharm.com	CHINA	1811	55
Nanjing Finetech Chemical Co., Ltd.	025-85710122 17714198479	sales@fine-chemtech.com	CHINA	885	55
ATK CHEMICAL COMPANY LIMITED	+undefined-21-51877795	ivan@atkchemical.com	China	32480	60
career henan chemical co	+86-0371-86658258	sales@coreychem.com	China	29914	58
Biochempartner	0086-13720134139	candy@biochempartner.com	CHINA	967	58
Cangzhou Wanyou New Material Technology Co.,Ltd	18631714998	sales@czwytech.com	CHINA	906	58
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19553	58
Chongqing Chemdad Co., Ltd	+86-023-61398051 +8613650506873	sales@chemdad.com	China	39916	58
CONIER CHEM AND PHARMA LIMITED	+8618523575427	sales@conier.com	China	47465	58

WZ4002 관련 검색:

BKM-120 WZ8040 WZB117 WZ4141 AP26113 Lenvatinib Afatinib (BIBW 2992) Vandetanib Gefitinib Alisertib (MLN8237) Erlotinib hydrochloride Capmatinib Ceritinib (LDK378) Selumetinib Cabozantinib Dabrafenib Dacomitinib (PF299804) WZ4141R